Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults.
The financing round will fund the improvement of the company’s technology platform for the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback